Boardroom Alpha
Research library
SPACs · Jul 15, 2026

SPAC Market Update July 15, 2026: Churchill Capital IX to Liquidate, PCSC-Freenome Vote

Churchill Capital IX to Liquidate. Archimedes Tech SPAC Partners II Co (ATII) adds $23M to PIPE financing. Separately, Perceptive Capital Solutions Corp (PCSC) holds its merger vote with Freenome Holdings, Inc., an early-cancer-detection testing company.

SPAC IPO Update — July 15, 2026

No SPAC IPOs priced on July 15, 2026; July MTD now stands at 8 IPOs totaling $1.80B over 15 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 8Prior: 21MoM: -13
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
21
Jun ’26
8
Jul ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 8 IPOs ($1.80B) vs. first 15 days of last month 12 ($2.29B) · 12-mo avg: 17/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Jul 14 JONE Jones Ventures INTL Acquisition1 Corp $200M 100.0%
Jul 13 RACD RESEARCH ALLIANCE CORP IV $75M 100.0%
Jul 10 SAMO SAMOS ENERGY ACQUISITION CORP $200M 100.0%
Jul 08 FDMM FREEDOM METALS ACQUISITION CORP $275M 100.0%
Jul 07 BCCQ BLEICHROEDER ACQUISITION CORP III $300M  $45M overallotment 100.0%
Source: Boardroom Alpha

Daily SPAC Update — July 15, 2026

SPAC VOTE RESULTS
OAK WOODS ACQUISITION CORP (OAKU) * Extend to March 28, 20271,269,163 redeemed

MERGER VOTES
Perceptive Capital Solutions Corp (PCSC) + Freenome Holdings, Inc.
Freenome Holdings, Inc. develops blood-based tests for early cancer detection. It employs a multiomics platform that analyzes various signals in the blood, utilizing artificial intelligence and machine learning to identify subtle indicators of cancer. This approach addresses the complexity of cancer, aiming to detect the disease when it is most treatable.

SPAC DEAL & EXTENSION VOTES SET
Bynordic Acquisition Corp (BYNO) * EXTENSION VOTE SET: August 6, 2026 * trust $13.09

EXTENSION VOTES
COMPASS DIGITAL ACQUISITION CORP (CDAQ)vote July 15, 2026 -> extend from July 20, 2026 through January 20, 2027

SPAC EXTENSIONS
BAYVIEW ACQUISITION CORP (BAYA) * Extension FilingBayview Acquisition deposits $50,000 to extend its business combination deadline by one month to August 19, 2026.

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-07-07: AFJK + United Hydrogen Group Inc.

SEPARATE WARRANTS/RIGHTS
July 20: VIKING ACQUISITION CORP II (VII)
July 17: RMG ML SPORTS HOLDINGS (SHOT)
July 14: BURTECH ACQUISITION CORP II (BRKH)
July 13: TEXAS VENTURES ACQUISITION IV CORP (TVIV)
July 13: YORKVILLE INTERNATIONAL CAPITAL CORP (YICC)

OTHER SPAC NEWS
ARCHIMEDES TECH SPAC PARTNERS II CO (ATII) * PIPE UpdatePIPE financing of 2.3M Pubco shares at $10 raises about $23M; closing contingent on the concurrent closing of the proposed business combination.
CHURCHILL CAPITAL CORP IX (CCIX) * Liquidation -> 2026-07-28
CHURCHILL CAPITAL CORP IX (CCIX) * Trust Update * trust $10.89

SPAC LIQUIDATIONS
CHURCHILL CAPITAL CORP IX (CCIX) -> Liquidation on July 28

SPAC Executive & Director Moves — July 15, 2026

SPAC Executive & Director Moves
Company Ticker Moves
CHURCHILL CAPITAL CORP XII CXII
  • On July 13, 2026, Paul Lapping was appointed as a Director and chairperson of the Audit Committee at Churchill Capital Corp XII, succeeding William Sherman who remains on the committee.  (view source)
RESEARCH ALLIANCE CORP IV RACD
  • On July 10, 2026, Alan Musso and John Maslowski were appointed to the board of directors and various committees of the Company.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — July 15, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
STONEBRIDGE ACQUISITION II CORP APAC 60.4% $ 14.03 Pre-Deal
RISING DRAGON ACQUISITION CORP RDAC 18.9% $ 6.30 Announced
CHURCHILL CAPITAL CORP XI CCXI 11.4% $ 15.97 Announced
PERCEPTIVE CAPITAL SOLUTIONS CORP PCSC 7.9% $ 11.85 Announced
SPARK I ACQUISITION CORP SPKL 3.3% $ 12.50 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
JATT II ACQUISITION CORP TBD -6.4% $ 10.76 Announced
AIMEI HEALTH TECHNOLOGY CO LTD AFJK -4.5% $ 11.69 Pre-Deal
BLUE ACQUISITION CORP BACC -4.4% $ 10.55 Announced
PLUM ACQUISITION CORP IV PLMK -3.5% $ 10.90 Announced
EUREKA ACQUISITION CORP EURK -3.0% $ 12.50 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What were the ATII PIPE financing terms?
    Archimedes Tech SPAC Partners II Co (ATII) said the PIPE covers 2.3M Pubco shares at $10, raising about $23M, contingent on closing its proposed business combination.
  • What target did PCSC bring to a merger vote?
    Perceptive Capital Solutions Corp (PCSC) held a merger vote tied to Freenome Holdings, Inc., which develops blood-based tests for early cancer detection using a multiomics platform.
  • What happened at the OAKU extension vote?
    Oak Woods Acquisition Corp (OAKU) won approval to extend its deadline to March 28, 2027, with 1,269,163 shares redeemed.
  • How many SPAC IPOs priced in July 2026 through July 15?
    8 SPAC IPOs priced for $1.80B through July 15, 2026, compared with 12 IPOs for $2.29B over the same span in June 2026.
  • When is the BYNO extension vote scheduled?
    Bynordic Acquisition Corp (BYNO) set an extension vote for August 6, 2026.


ShareXLinkedIn

Published Jul 15, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer